Consequently, it is hypothesized that akin to SIRT1, SIRT3 might play a pivotal role in circadian rhythm disruptions in OSA patients, potentially triggering metabolic impairments and ultimately leading to NAFLD. The gene discussed is SIRT3; the disease is metabolic dysfunction-associated steatotic liver disease.